Research library

B

grade

The integration of a multidisciplinary Bone Health Clinic for spine patients showed high rates of pharmacotherapy initiation and favorable early surgical outcomes, though barriers to treatment access remain significant.

60% demonstrated improved bone mineral density, with an average T-score gain of 0.6 ± 0.5.

summary

D

grade

Clinicians should assess individual fracture risks in postmenopausal women with osteopenia and consider treatment options based on risk level and patient preferences.

Not reported in abstract.

summary

B

grade

Romosozumab may reduce the risk of osteoporotic fractures more effectively than PTH receptor agonists in certain populations, but further research is needed to confirm these findings and assess long-term outcomes.

HR for osteoporotic fractures in ROMO users vs PTH receptor agonists: 0.711, 95% CI: 0.542-0.931.

summary

B

grade

The study reports significant reductions in pain and disability scores following 360° lumbar arthroplasty, but findings are based on a small sample with no long-term follow-up.

Total VAS score decreased by 9 points (89% reduction), n=24.

summary

A

grade

Starting osteoporosis treatment with anabolic agents may lead to a significant reduction in fracture risk for patients at very high fracture risk, but further investigation is needed to confirm these findings.

0.43 (95% CI 0.34-0.54) pooled summary estimate for vertebral fractures.

summary